| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 4, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.055 per share, payable on December 16, 2008 to shareholders of record on...
-
Oct 29, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for...
-
Oct 23, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal year 2009 on Thursday, November 6, 2008 at approximately 8:00 a.m....
-
Oct 6, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, privately-held...
-
Oct 3, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Perrigo Chairman and CEO Joseph C. Papa will present at the JMP Securities 2008 Healthcare Focus Conference on Monday, October 6, at...
-
Sep 18, 2008
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that the Hatch-Waxman litigation relating to Miconazole Nitrate Vaginal Cream and Suppository between Johnson & Johnson and Perrigo...
-
Sep 16, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has acquired JB Laboratories for approximately $44 million in cash. Based in Holland, Michigan, privately-held JB Laboratories is...
-
Sep 15, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Judy Brown, Perrigo's CFO will present at the Merrill Lynch Global Pharmaceutical Conference on Tuesday, September 16 at the Merrill...
-
Sep 8, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has acquired the exclusive U.S. rights to sell and distribute Levocetirizine tablets, the generic version of UCB's Xyzal®...
-
Aug 18, 2008- Full year revenue increased $375 million, or 26 percent, to a record $1.8 billion, including $500 million for the fourth quarter
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for its fourth quarter and full year ended June 28, 2008. Perrigo's Chairman and CEO Joseph C. Papa commented, "For the third...